Related Experiment Video
Updated: Aug 14, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.9K
COVID-19 Vaccines-All You Want to Know.
Akira A Shishido1,2, Ashley H Barnes1, Shivakumar Narayanan1
1Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland.
Seminars in Respiratory and Critical Care Medicine
|January 16, 2023
Summary
The COVID-19 pandemic spurred rapid vaccine development, advancing vaccinology. Challenges like immune evasion and waning immunity persist, impacting universal vaccine effectiveness against SARS-CoV-2 variants.
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- The COVID-19 pandemic caused by SARS-CoV-2 presented a global health emergency.
- Rapid development of novel vaccines has significantly advanced vaccinology.
- Existing vaccines face challenges including viral immune evasion and waning immunity.
Approach:
- This review evaluates the development of current SARS-CoV-2 vaccines.
- It assesses vaccine effectiveness against the virus.
- The review examines challenges to vaccine deployment and universal effectiveness.
Key Points:
- Novel vaccine platforms have accelerated the response to the SARS-CoV-2 pandemic.
- Key challenges include SARS-CoV-2 variants' immune evasion, diminishing immune responses, and unknown correlates of protection.
- Optimizing vaccine efficacy in special populations and addressing waning immunity are critical.
Conclusions:
- Despite advancements, universal SARS-CoV-2 vaccine effectiveness is hindered by viral evolution and immunological factors.
- Further research is needed to overcome challenges in vaccine deployment and ensure long-term protection.
- Addressing immune evasion and waning immunity is crucial for global public health strategies.
Related Concept Videos
01:51Vaccinations
45.1K
Overview
45.1K
01:30Cancer Vaccines
476
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
476
02:50Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
01:29Microorganisms in Medicine and Therapeutics
128
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
128